Answers are grounded in this paper and cite their sources.
Interest in the role of donor-specific human leukocyte antibodies in liver transplantation has been rekindled recently. Emerging evidence suggests that these antibodies may cause injury to the liver allograft. Here we review the clinical literature, highlight controversial results, and propose a path forward for the definition and better understanding of antibody-mediated injury to the liver.
No takes yet. Share an insight, caveat, or question.
Taner et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: